0001140361-15-023771.txt : 20150610 0001140361-15-023771.hdr.sgml : 20150610 20150610153625 ACCESSION NUMBER: 0001140361-15-023771 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150608 FILED AS OF DATE: 20150610 DATE AS OF CHANGE: 20150610 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REPLIGEN CORP CENTRAL INDEX KEY: 0000730272 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 042729386 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 41 SEYON STREET STREET 2: BUILDING 1, SUITE 100 CITY: WALTHAM STATE: MA ZIP: 02453 BUSINESS PHONE: 7814499560 MAIL ADDRESS: STREET 1: 41 SEYON STREET STREET 2: BUILDING 1, SUITE 100 CITY: WALTHAM STATE: MA ZIP: 02453 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Benjamin Howard CENTRAL INDEX KEY: 0001393547 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-14656 FILM NUMBER: 15923459 MAIL ADDRESS: STREET 1: 401 MARRETT ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 doc1.xml FORM 4 X0306 4 2015-06-08 0 0000730272 REPLIGEN CORP RGEN 0001393547 Benjamin Howard C/O REPLIGEN CORPORATION 41 SEYON ST, BLDG 1, STE 100 WALTHAM MA 02453 0 0 0 1 VP Business Development Common stock 2015-06-08 4 S 0 27303 38.3243 D 19251 D Common stock 2015-06-09 4 S 0 7697 37.4803 D 11554 D $38.3243 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.975 to $38.68, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. $37.4803 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.26 to $37.93, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. /s/ Jeffrey P. Leduc (Attorney in Fact) 2015-06-10